Ascendis Pharma A/S (ASND) — SEC Filings

Latest SEC filings for Ascendis Pharma A/S. Recent 8-A12B/A filing on Apr 20, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Ascendis Pharma A/S on SEC EDGAR

Overview

Ascendis Pharma A/S (ASND) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-A12B/A filed on Apr 20, 2026: Ascendis Pharma A/S filed an amendment to its registration of securities on Form 8-A12B/A on April 20, 2026. This filing relates to the registration of securities under Section 12(b) of the Securities Exchange Act of 1934. The company's business address is Tuborg Boulevard 12, Hellerup, Denmark.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant filing sentiment for Ascendis Pharma A/S is neutral.

Filing Type Overview

Ascendis Pharma A/S (ASND) has filed 1 8-A12B/A, 43 6-K, 1 20-F, 5 SC 13G/A with the SEC between Nov 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

Ascendis Pharma Files 8-A12B/A Amendment — 8-A12B/A · Apr 20, 2026 Risk: low
Ascendis Pharma A/S filed an amendment to its registration of securities on Form 8-A12B/A on April 20, 2026. This filing relates to the registration of securiti
6-K Filing — 6-K · Apr 20, 2026
6-K Filing — 6-K · Apr 8, 2026
6-K Filing — 6-K · Apr 8, 2026
6-K Filing — 6-K · Apr 7, 2026
Ascendis Pharma Files Routine 6-K; No New Material Info — 6-K · Mar 24, 2026
Ascendis Pharma A/S filed a 6-K on March 24, 2026, which is a routine report for foreign issuers. This specific filing, with accession number 0001193125-26-1217
Ascendis Pharma Files December 2025 6-K Report — 6-K · Dec 30, 2025 Risk: low
Ascendis Pharma A/S, a pharmaceutical company, filed a Form 6-K on December 30, 2025. This report is for the month of December 2025 and is being filed under the
6-K Filing — 6-K · Dec 10, 2025
Ascendis Pharma Files 6-K Report — 6-K · Nov 26, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on November 26, 2025, for the month of November 2025. The company, incorporated in G7 with its principal executive offices
6-K Filing — 6-K · Nov 12, 2025
Ascendis Pharma Files 6-K for S-8 Registration — 6-K · Oct 22, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on October 22, 2025, to report information as a foreign private issuer. The filing is related to their registration stateme
Ascendis Pharma Files October 2025 6-K Report — 6-K · Oct 15, 2025 Risk: low
Ascendis Pharma A/S, a biopharmaceutical company, filed a Form 6-K on October 15, 2025. This report is for the month of October 2025 and is filed under the Secu
Ascendis Pharma Files 6-K for S-8 Registration — 6-K · Oct 8, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on October 8, 2025, to report information as a foreign private issuer. The filing is related to their registration statemen
Ascendis Pharma Files 6-K for September 2025 — 6-K · Sep 30, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on September 30, 2025, to report information as a foreign private issuer. The filing indicates that the company will file a
Ascendis Pharma Files 6-K, Incorporates by Reference — 6-K · Sep 10, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on September 10, 2025, to report information as a foreign private issuer. The filing is related to registration statements
Ascendis Pharma Files 6-K, Incorporates by Reference — 6-K · Aug 13, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on August 13, 2025, to report information as a foreign private issuer. The filing is related to registration statements on
Ascendis Pharma Reports Q2 2025 Financial Results — 6-K · Aug 7, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on August 7, 2025, to report its financial results for the fiscal quarter ended June 30, 2025. The filing includes a press
Ascendis Pharma Files 6-K for June 30, 2025 — 6-K · Aug 7, 2025 Risk: low
Ascendis Pharma A/S filed a 6-K report as of June 30, 2025. The filing includes financial data and details related to its operations, such as issued capital and
Ascendis Pharma Files 6-K for S-8 Registration — 6-K · Jul 28, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on July 28, 2025, to report information as a foreign private issuer. The filing is related to their registration statements
Ascendis Pharma Files 6-K, Incorporates by Reference — 6-K · Jul 9, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on July 9, 2025, to report information as a foreign private issuer. The filing is related to registration statements on For
Ascendis Pharma Files 6-K for S-8 Registration Updates — 6-K · Jun 27, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on June 27, 2025, to incorporate by reference into its existing Form S-8 registration statements. These S-8 filings are rel
Ascendis Pharma Files 6-K for June 2025 — 6-K · Jun 11, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on June 11, 2025, to report information as a foreign private issuer. The filing is incorporated by reference into several S
Ascendis Pharma Files 6-K, Incorporates into S-8 Filings — 6-K · Jun 9, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on June 9, 2025, to report information as a foreign private issuer. This filing is incorporated by reference into several o
Ascendis Pharma Files 6-K for S-8 Registration — 6-K · Jun 2, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on June 2, 2025, to incorporate by reference into its existing S-8 registration statements. These statements relate to the
Ascendis Pharma Files 6-K for S-8 Registration — 6-K · May 28, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on May 28, 2025, to incorporate by reference into its existing Form S-8 registration statements. These statements are used
Ascendis Pharma Files 6-K Report — 6-K · May 14, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on May 14, 2025, to report its activities as a foreign private issuer. The filing indicates that the company is subject to
Ascendis Pharma A/S Reports Q1 2025 Financial Results — 6-K · May 1, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on May 1, 2025, to report its financial results for the fiscal quarter ended March 31, 2025. The filing includes a press re
Ascendis Pharma Files 6-K with Q1 2025 Financials — 6-K · May 1, 2025 Risk: low
Ascendis Pharma A/S filed a 6-K report on May 1, 2025, for the period ending March 31, 2025. The filing includes financial information such as share premium and
Ascendis Pharma A/S Announces Annual General Meeting Notice — 6-K · Apr 29, 2025 Risk: low
Ascendis Pharma A/S has filed a Form 6-K on April 29, 2025, to provide a convening notice for its Annual General Meeting. This notice informs the company's shar
Ascendis Pharma Files Routine 6-K Disclosure — 6-K · Apr 9, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on April 9, 2025, to report information as a foreign private issuer. The filing does not contain specific financial figures
Ascendis Pharma Files March 2025 6-K Report — 6-K · Mar 31, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on March 31, 2025, for the month of March 2025. This report is a routine filing for foreign private issuers and does not co
Ascendis Pharma Files 6-K for SEC Reporting — 6-K · Mar 28, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on March 28, 2025, to report information as a foreign private issuer. The filing is incorporated by reference into several
Ascendis Pharma Files Routine 6-K Disclosure — 6-K · Mar 20, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on March 20, 2025, to report its activities as a foreign private issuer. The filing does not contain specific financial fig
Ascendis Pharma Files 6-K, Incorporates into S-8 Filings — 6-K · Mar 12, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on March 12, 2025, to report information as a foreign private issuer. The filing is incorporated by reference into several
Ascendis Pharma Files 6-K Report — 6-K · Feb 12, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on February 12, 2025, to report information as a foreign private issuer. The filing indicates that the company is subject t
Ascendis Pharma A/S Files 20-F for FY2024 — 20-F · Feb 12, 2025 Risk: medium
Ascendis Pharma A/S filed its 20-F for the fiscal year ending December 31, 2024. The filing, submitted on February 12, 2025, provides a comprehensive overview o
Ascendis Pharma Files 6-K Report — 6-K · Jan 15, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on January 15, 2025, to report its activities for the month of January 2025. The filing is a report of a foreign private is
Ascendis Pharma Files Routine 6-K — 6-K · Jan 13, 2025 Risk: low
Ascendis Pharma A/S filed a Form 6-K on January 13, 2025, to report information as a foreign private issuer. The filing does not contain specific financial figu
Ascendis Pharma Files 6-K for December 2024 — 6-K · Dec 30, 2024 Risk: low
Ascendis Pharma A/S filed a Form 6-K on December 30, 2024, to report information as a foreign private issuer. The filing is for the month of December 2024 and i
Ascendis Pharma Files 6-K for December 2024 — 6-K · Dec 17, 2024 Risk: low
Ascendis Pharma A/S filed a Form 6-K on December 17, 2024, to report information as a foreign private issuer. The filing is for the month of December 2024 and i
Ascendis Pharma Files 6-K Report — 6-K · Dec 12, 2024 Risk: low
Ascendis Pharma A/S filed a Form 6-K on December 12, 2024, to report its activities for the month of December 2024. The filing is a routine report for foreign p
Ascendis Pharma Files 6-K with SEC — 6-K · Dec 11, 2024 Risk: low
Ascendis Pharma A/S filed a Form 6-K on December 11, 2024, to report information as a foreign private issuer. The filing indicates that the company will file an
SC 13G/A Filing — SC 13G/A · Nov 14, 2024
Ascendis Pharma Reports Q3 2024 Financial Results — 6-K · Nov 14, 2024 Risk: low
Ascendis Pharma A/S filed a Form 6-K on November 14, 2024, to report its financial results for the fiscal quarter ended September 30, 2024. The filing includes
SC 13G/A Filing — SC 13G/A · Nov 14, 2024
SC 13G/A Filing — SC 13G/A · Nov 14, 2024
Ascendis Pharma Files 6-K with Q3 2024 Financials — 6-K · Nov 14, 2024 Risk: low
Ascendis Pharma A/S filed a 6-K report on November 14, 2024, detailing financial information as of September 30, 2024. The filing includes data on financial ass
SC 13G/A Filing — SC 13G/A · Nov 14, 2024
Ascendis Pharma Files 6-K Report — 6-K · Nov 13, 2024 Risk: low
Ascendis Pharma A/S filed a Form 6-K on November 13, 2024. This report is for the month of November 2024 and is filed by a foreign private issuer. The company i
SC 13G/A Filing — SC 13G/A · Nov 12, 2024

Frequently Asked Questions

What are the latest SEC filings for Ascendis Pharma A/S (ASND)?

Ascendis Pharma A/S has 50 recent SEC filings from Nov 2024 to Apr 2026, including 43 6-K, 5 SC 13G/A, 1 8-A12B/A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ASND filings?

Across 50 filings, the sentiment breakdown is: 50 neutral. The dominant sentiment is neutral.

Where can I find Ascendis Pharma A/S SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Ascendis Pharma A/S (ASND) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.